1[1]Rordorf G, Cramer SC, Efird JT, et al. Pharmacological elevation of blood pressure in acute stroke. Stroke, 1997,28: 2133-2137.
2[2]Rordorf G, Koroshetz WJ, Ezzeddine MA, et al. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology, 2001, 56: 1210-1213.
3[3]Legos JJ, Mangoni AA, Read SJ, et al. Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the rat.J Neurosci Methods, 2002, 30: 159-66.
4[4]Schmidley JW. Free radicals in central nervous system ischemia. Stroke, 1990, 21: 1086-1090.
5[5]Haley EC, Kassell NF, Alves WM, et al. Phas trial of tirilazad in aneurismal subarachnoid hemorrhage. J Neurosurg, 1995, 82: 786-790.
6[6]Mori E, Ember J, Copland B R, et al. Effect of tirilazad mesylate on middle cerebral artery occlusion reperfusion human primates. Cerebrovasc Dis, 1995, 5: 342-349.
7[7]Niki E, Yamato Y, Komouro E, et al. Membrane damage due to lipid oxidation. Am J Clin Nutr, 1991, 53:201-205.
8[8]Branghler JM, Slis H, Meldrun BS. Central nervous system trama and stroke: Biochemical consideration. Free Radical biolmed, 1989, 6: 289-292.
9[10]Uyama H. Protective effects of superoxide on acute reperfusion injury of gerbil brain. Free Radical Biolmed, 1990,7: 265-268.
10Tei H,Uchiyarna S,Ohara K,et al.Deteriorating is chemic stroke in clinical categories classified by the Oxfordshire Community Stroke Proiect[J]. Sa'oke,2000,31:204%-2054.
